Outpatient transcranial magnetic stimulation therapy (TMS) for progressive supranuclear palsy (PSP)

Phase 4

Recruiting

• Conditions: G23.1; Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

• Registration Number: DRKS00030943
• Lead Sponsor: niversitätsklinikum Bonn

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Diagnosis of PSP with decreased stance and gait insecurity.

Exclusion Criteria

Contraindications for TMS therapy.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evidence of improvement in gait and stance on the last day of TMS treatment using PosturoMed, Timed up and go and 8 meter walking test.

Secondary Outcome Measures

Name	Time	Method
Evidence of improvement in general symptoms measured by PSP Rating Scale.